Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Clinical Value of Autoantibodies in Rheumatoid Arthritis
Serena Bugatti, Antonio Manzo, Carlomaurizio Montecucco, et al.
Frontiers in Medicine (2018) Vol. 5
Open Access | Times Cited: 88

Showing 1-25 of 88 citing articles:

From Rheumatoid Factor to Anti-Citrullinated Protein Antibodies and Anti-Carbamylated Protein Antibodies for Diagnosis and Prognosis Prediction in Patients with Rheumatoid Arthritis
Chao‐Yi Wu, Huang‐Yu Yang, Shue‐Fen Luo, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 2, pp. 686-686
Open Access | Times Cited: 92
Anti-Citrullinated Protein Antibodies in Patients with Rheumatoid Arthritis: Biological Effects and Mechanisms of Immunopathogenesis
Chao‐Yi Wu, Huang‐Yu Yang, Jenn‐Haung Lai
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 11, pp. 4015-4015
Open Access | Times Cited: 76
Seronegative autoimmune diseases: A challenging diagnosis
Marco Vincenzo Lenti, Carlo Maria Rossi, Federica Melazzini, et al.
Autoimmunity Reviews (2022) Vol. 21, Iss. 9, pp. 103143-103143
Closed Access | Times Cited: 66
Exosomes as biomarkers and therapeutic delivery for autoimmune diseases: Opportunities and challenges
Fang Yang, Jing Ni, Yun-Sheng Wang, et al.
Autoimmunity Reviews (2022) Vol. 22, Iss. 3, pp. 103260-103260
Closed Access | Times Cited: 59
Smoking, alcohol consumption and disease-specific outcomes in rheumatic and musculoskeletal diseases (RMDs): systematic reviews informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs
Maud Wieczorek, James M. Gwinnutt, Maxime Ransay-Colle, et al.
RMD Open (2022) Vol. 8, Iss. 1, pp. e002170-e002170
Open Access | Times Cited: 56
Seronegative rheumatoid arthritis: one year in review 2023
Ludovico De Stefano, Bernardo D’Onofrio, Saviana Gandolfo, et al.
Clinical and Experimental Rheumatology (2023)
Open Access | Times Cited: 29
Serum metabolomic and lipidomic profiling identifies diagnostic biomarkers for seropositive and seronegative rheumatoid arthritis patients
Hemi Luan, Wanjian Gu, Hua Li, et al.
Journal of Translational Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 50
Circulating inflammatory cell profiling and periodontitis: A systematic review and meta-analysis
Rizky A. Irwandi, Sandra Olivia Kuswandani, Simon Harden, et al.
Journal of Leukocyte Biology (2022) Vol. 111, Iss. 5, pp. 1069-1096
Open Access | Times Cited: 26
14–3-3 eta (η) protein as a promising marker for rheumatoid arthritis: relation to joint damage and subclinical atherosclerosis
Sahar A. Elsayed, Dalia Adel, Mohammed Zaki, et al.
Egyptian Rheumatology and Rehabilitation (2025) Vol. 52, Iss. 1
Open Access
Imaging Updates in Rheumatoid Arthritis
William R. Walter, Mohammad Samim
Seminars in Musculoskeletal Radiology (2025) Vol. 29, Iss. 02, pp. 156-166
Closed Access
Location and amount of joint involvement differentiates rheumatoid arthritis into different clinical subsets
Tjardo Maarseveen, M. Maurits, Lavinia Agra Coletto, et al.
Research Square (Research Square) (2025)
Open Access
Fluorescent probes in autoimmune disease research: current status and future prospects
Junli Chen, Mingkai Chen, Xiaolong Yu
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Autoimmune Rheumatic Diseases and Vascular Function: The Concept of Autoimmune Atherosclerosis
Ahmed M. Hedar, Martin Stradner, Andreas Roessler, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 19, pp. 4427-4427
Open Access | Times Cited: 32
Geraniol Suppresses Oxidative Stress, Inflammation, and Interstitial Collagenase to Protect against Inflammatory Arthritis
Muhammad Nasir Hayat Malik, Muhammad Tahir, Tariq G. Alsahli, et al.
ACS Omega (2023) Vol. 8, Iss. 40, pp. 37128-37139
Open Access | Times Cited: 12
Patient burden and joint inflammation during development of RA from arthralgia: is it similar in ACPA-positive and ACPA-negative disease?
Sarah J H Khidir, Doortje I Krijbolder, Herman Kasper Glas, et al.
Lara D. Veeken (2024) Vol. 63, Iss. 9, pp. 2336-2344
Open Access | Times Cited: 4
Biologics or Janus Kinase Inhibitors in Rheumatoid Arthritis Patients Who are Insufficient Responders to Conventional Anti-Rheumatic Drugs
Ennio Giulio Favalli, Gabriella Maioli, Roberto Caporali
Drugs (2024) Vol. 84, Iss. 8, pp. 877-894
Open Access | Times Cited: 4
The NADase enzyme CD38: an emerging pharmacological target for systemic sclerosis, systemic lupus erythematosus and rheumatoid arthritis
Thais Peclat, Bo Shi, John Varga, et al.
Current Opinion in Rheumatology (2020) Vol. 32, Iss. 6, pp. 488-496
Open Access | Times Cited: 28
A Serum Biomarker Panel of exomiR-451a, exomiR-25-3p and Soluble TWEAK for Early Diagnosis of Rheumatoid Arthritis
Samantha Rodríguez‐Muguruza, Antonio Altuna-Coy, Sonia Castro-Oreiro, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 25
Predictors of drug survival for biologic and targeted synthetic DMARDs in rheumatoid arthritis: Analysis from the TRA Clinical Electronic Registry
Ching-Tsai Lin, Wen‐Nan Huang, Wen‐Chan Tsai, et al.
PLoS ONE (2021) Vol. 16, Iss. 4, pp. e0250877-e0250877
Open Access | Times Cited: 24
Nanoengineered therapy aiming at the etiology of rheumatoid arthritis
Ruiqi Li, Yu Ma, Jin Pyo Hong, et al.
Nano Today (2021) Vol. 42, pp. 101367-101367
Closed Access | Times Cited: 24
Synovial and serum B cell signature of autoantibody-negative rheumatoid arthritis vs autoantibody-positive rheumatoid arthritis and psoriatic arthritis
Ludovico De Stefano, Serena Bugatti, Iolanda Mazzucchelli, et al.
Lara D. Veeken (2023) Vol. 63, Iss. 5, pp. 1322-1331
Closed Access | Times Cited: 10
Enalapril attenuated CFA provoked arthritic manifestation by modulating proinflammatory and anti-inflammatory cytokine network
Yusra Habib Khan, Sumera Qasim, Ambreen Malik Uttra, et al.
Life Sciences (2023) Vol. 324, pp. 121742-121742
Closed Access | Times Cited: 9
Peptidylarginine deiminase (PAD): A promising target for chronic diseases treatment
Pegah Mansouri, Pardis Mansouri, Esmaeil Behmard, et al.
International Journal of Biological Macromolecules (2024) Vol. 278, pp. 134576-134576
Closed Access | Times Cited: 3
Inflammatory correlates of the Patient Global Assessment of Disease Activity vary in relation to disease duration and autoantibody status in patients with rheumatoid arthritis
Serena Bugatti, Ludovico De Stefano, Bernardo D’Onofrio, et al.
Annals of the Rheumatic Diseases (2022) Vol. 81, Iss. 9, pp. 1206-1213
Closed Access | Times Cited: 15
Autoantigenic properties of the aminoacyl tRNA synthetase family in idiopathic inflammatory myopathies
Charlotta Preger, Antonella Notarnicola, Cecilia Hellström, et al.
Journal of Autoimmunity (2022) Vol. 134, pp. 102951-102951
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top